#USA #New York #Faruqi & Faruqi #Zynex #ZYXIQ

Overview

Faruqi & Faruqi, LLP, a prominent national securities law firm, has issued a critical reminder for Zynex, Inc. investors regarding the ongoing securities class action. This class action arises from various allegations of misconduct involving Zynex, particularly with respect to its financial disclosures and corporate governance practices. As the deadline for potential plaintiffs to join the action approaches on April 21, 2026, affected investors are urged to consider their legal avenues.

Background on the Allegations

The firm is currently scrutinizing claims against Zynex, specifically regarding actions taken from February 25, 2021, to December 15, 2025. The allegations against the company claim that it engaged in a series of deceptive practices that misled investors regarding its financial health and operational integrity. These include accusations that Zynex inflated its revenue by shipping more products than necessary and submitting fraudulent claims to its insurers.

In particular, it has been alleged that Zynex initiated a fraudulent overbilling scheme involving significant sums of money. For instance, on August 21, 2023, legal proceedings were launched against the company seeking over $23 million in damages related to these practices. The firm's legal action underscores the severe ramifications of Zynex's alleged misconduct, particularly its effect on stakeholders and the integrity of its financial reporting.

Recent Developments

Zynex's troubles came to a head when it reported a significant revenue shortfall in March 2025, which it attributed to slower payments from key payers, notably Tricare, the primary healthcare provider for U.S. military personnel. This revelation led to a drastic drop in the company’s stock price, further amplifying investor concerns regarding the company’s operational integrity.

Additionally, in July 2025, Zynex acknowledged its failure to comply with industry regulations and appointed a new CEO, which triggered yet another plunge in share value. The introduction of new leadership often brings hope for reform; however, the substantial loss in stock value left many investors feeling apprehensive.

Call to Action for Investors

Investors who purchased or acquired Zynex securities during the relevant period are encouraged to reach out to Faruqi & Faruqi for a consultation. The firm emphasizes that securing a role as lead plaintiff can be crucial for a collective resolution to the situation, thereby offering a mechanism for redress amidst the ongoing turbulence. It's also worth noting that any member of the class can move to be a lead plaintiff through their chosen counsel or may opt to remain a passive participant in the proceedings.

Furthermore, insights from whistleblowers or former employees can provide additional context regarding the alleged misconduct at Zynex, which could prove beneficial for the ongoing investigation. Anyone with pertinent information is encouraged to share their experience with the attorneys at Faruqi & Faruqi.

Conclusion

As the April 21 deadline approaches, impacted Zynex investors should act promptly to protect their rights. Navigating securities class actions can be convoluted, but legal expertise may provide the necessary support to achieve a favorable resolution. Whether investors choose to take an active role in the proceedings or remain observers, understanding their rights and the context of the allegations against Zynex is critically important in this ongoing legal battle.